<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">36366465</PMID><DateCompleted><Year>2022</Year><Month>11</Month><Day>22</Day></DateCompleted><DateRevised><Year>2023</Year><Month>01</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>14</Volume><Issue>11</Issue><PubDate><Year>2022</Year><Month>Oct</Month><Day>27</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Infection with SARS-CoV-2 Variants Is Associated with Different Long COVID Phenotypes.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">2367</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v14112367</ELocationID><Abstract><AbstractText>COVID-19 has been associated with a broad range of long-term sequelae, commonly referred to as "long-COVID" or "post-COVID-19" syndrome. Despite an increasing body of literature, long COVID remains poorly characterized. We retrospectively analysed data from electronic medical records of patients admitted to the post-COVID-19 outpatient service of the Infectious and Tropical Diseases Unit, Careggi University Hospital, Florence, Italy, between June 2020 and June 2021, 4-12 weeks after hospital discharge. A total of 428 patients, 41% women, median age 64 years, underwent a follow-up visit a median 53 days after hospital discharge. Overall, 76% patients reported at least one persistent symptom, including dyspnoea (37%), chronic fatigue (36%), insomnia (16%), visual disorders (13%) and brain fog (13%). Increasing oxygen support (OR 1.4, 95% CI 1.1-1.8), use of immunosuppressants (OR 6.4, 95% CI 1.5-28) and female sex (OR 1.8, 95% CI 1.1-2.9) were associated with a higher risk of long COVID symptoms. Comparison between symptomatic patients infected in the period March-December 2020 (prevalent circulation of wild-type SARS-CoV-2) with those infected in the period January-April 2021 (prevalent circulation of B.1.1.7 Alpha variant) showed a significant modification in the pattern of symptoms belonging to the neurological and cognitive/emotional categories. Our findings confirmed shortness of breath and chronic fatigue as the most frequent long COVID manifestations, while female sex and severe COVID-19 course were the main risk factors for developing lingering symptoms. SARS-CoV-2 variants may induce different long COVID phenotypes, possibly due to changes in cell tropism and differences in viral-host interaction.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Spinicci</LastName><ForeName>Michele</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-5377-7118</Identifier><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Graziani</LastName><ForeName>Lucia</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tilli</LastName><ForeName>Marta</ForeName><Initials>M</Initials><Identifier Source="ORCID">0000-0002-2097-2443</Identifier><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nkurunziza</LastName><ForeName>Jerusalem</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vellere</LastName><ForeName>Iacopo</ForeName><Initials>I</Initials><Identifier Source="ORCID">0000-0003-3883-0766</Identifier><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Borchi</LastName><ForeName>Beatrice</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mencarini</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Campolmi</LastName><ForeName>Irene</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gori</LastName><ForeName>Leonardo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giovannoni</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Health Science, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Amato</LastName><ForeName>Carla</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Health Science, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Livi</LastName><ForeName>Luca</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Health Science, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rasero</LastName><ForeName>Laura</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Health Science, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fattirolli</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiac Rehabilitation Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marcucci</LastName><ForeName>Rossella</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Atherothrombotic Disease Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Giusti</LastName><ForeName>Betti</ForeName><Initials>B</Initials><Identifier Source="ORCID">0000-0002-8708-9444</Identifier><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Atherothrombotic Disease Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olivotto</LastName><ForeName>Iacopo</ForeName><Initials>I</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Cardiomyopathy Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tomassetti</LastName><ForeName>Sara</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracovascular Medicine, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lavorini</LastName><ForeName>Federico</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracovascular Medicine, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maggi</LastName><ForeName>Laura</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-2862-9591</Identifier><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Annunziato</LastName><ForeName>Francesco</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Flow Cytometry Diagnostic Center and Immunotherapy (CDCI), Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Marchionni</LastName><ForeName>Niccol&#xf2;</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cardiothoracovascular Medicine, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zammarchi</LastName><ForeName>Lorenzo</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-0892-8404</Identifier><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bartoloni</LastName><ForeName>Alessandro</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-9758-1523</Identifier><AffiliationInfo><Affiliation>Department of Experimental &amp; Clinical Medicine, University of Florence, 50134 Florence, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Infectious and Tropical Diseases Unit, Careggi University Hospital, 50134 Florence, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><SupplMeshList><SupplMeshName Type="Organism" UI="C000711908">SARS-CoV-2 variants</SupplMeshName></SupplMeshList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015673" MajorTopicYN="Y">Fatigue Syndrome, Chronic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010641" MajorTopicYN="N">Phenotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">VOC</Keyword><Keyword MajorTopicYN="N">long COVID</Keyword><Keyword MajorTopicYN="N">post-COVID-19</Keyword><Keyword MajorTopicYN="N">predictors</Keyword><Keyword MajorTopicYN="N">risk factors</Keyword><Keyword MajorTopicYN="N">variant</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>10</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>10</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>11</Month><Day>11</Day><Hour>1</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>11</Month><Day>12</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>11</Month><Day>15</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>10</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36366465</ArticleId><ArticleId IdType="pmc">PMC9698829</ArticleId><ArticleId IdType="doi">10.3390/v14112367</ArticleId><ArticleId IdType="pii">v14112367</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>World Health Organization . Weekly Epidemiological Update on COVID-19-8 June 2022. 95th ed. WHO; Geneva, Switzerland: 2022.</Citation></Reference><Reference><Citation>Smith M.P. Estimating total morbidity burden of COVID-19: Relative importance of death and disability. J. Clin. Epidemiol. 2022;142:54&#x2013;59. doi: 10.1016/j.jclinepi.2021.10.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jclinepi.2021.10.018</ArticleId><ArticleId IdType="pmc">PMC8547965</ArticleId><ArticleId IdType="pubmed">34715312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Z., McGoogan J.M. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China: Summary of a report of 72,314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020;323:1239&#x2013;1242. doi: 10.1001/jama.2020.2648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2648</ArticleId><ArticleId IdType="pubmed">32091533</ArticleId></ArticleIdList></Reference><Reference><Citation>Nabavi N. Long COVID: How to define it and how to manage it. BMJ. 2020;370:m3489. doi: 10.1136/bmj.m3489.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m3489</ArticleId><ArticleId IdType="pubmed">32895219</ArticleId></ArticleIdList></Reference><Reference><Citation>UK National Institute for Health and Care Excellence  COVID-19 Rapid Guideline: Managing the Long-Term Effects of COVID-19. Mar 1, 2022.  [(accessed on 14 February 2022)].  Available online:  https://www.nice.org.uk/guidance/ng188/resources/covid19-rapidguideline-managing-the-longterm-effects-of-covid19-pdf-51035515742.</Citation><ArticleIdList><ArticleId IdType="pubmed">33555768</ArticleId></ArticleIdList></Reference><Reference><Citation>US Centers for Disease Control and Prevention  Evaluating and Caring for Patients with Post-COVID Conditions: Interim Guidance.  [(accessed on 14 February 2022)];2021 June 14; Available online:  https://www.cdc.gov/coronavirus/2019-ncov/hcp/clinical-care/post-covidindex.html.</Citation></Reference><Reference><Citation>Shah W., Hillman T., Playford E.D., Hishmeh L. Managing the long term effects of COVID-19: Summary of NICE, SIGN, and RCGP rapid guideline. BMJ. 2021;372:n136. doi: 10.1136/bmj.n136.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., O&#x2019;Hara M., Suett J., Dahmash D., Bugaeva P., et al. Characterising long COVID: A living systematic review. BMJ Glob. Health. 2021;6:e005427. doi: 10.1136/bmjgh-2021-005427.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjgh-2021-005427</ArticleId><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Crook H., Raza S., Nowell J., Young M., Edison P. Long COVID-mechanisms, risk factors, and management. BMJ. 2021;374:n1648. doi: 10.1136/bmj.n1648.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n1648</ArticleId><ArticleId IdType="pubmed">34312178</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehandru S., Merad M. Pathological sequelae of long-haul COVID. Nat. Immunol. 2022;23:194&#x2013;202. doi: 10.1038/s41590-021-01104-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-021-01104-y</ArticleId><ArticleId IdType="pmc">PMC9127978</ArticleId><ArticleId IdType="pubmed">35105985</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Pawelek P. Prevalence of Ongoing Symptoms Following Coronavirus (COVID-19) Infection in the UK: 1 June 2022. UK Office for National Statistics.  [(accessed on 1 October 2022)]; Available online:  https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/conditionsanddiseases/bulletins/prevalenceofongoingsymptomsfollowingcoronaviruscovid19infectionintheuk/1june2022.</Citation></Reference><Reference><Citation>PHOSP-COVID Collaborative Group Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: A prospective observational study. Lancet Respir. Med. 2022;10:761&#x2013;775. doi: 10.1016/S2213-2600(22)00127-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00127-8</ArticleId><ArticleId IdType="pmc">PMC9034855</ArticleId><ArticleId IdType="pubmed">35472304</ArticleId></ArticleIdList></Reference><Reference><Citation>Fumagalli C., Zocchi C., Tassetti L., Silverii M.V., Amato C., Livi L., Giovannoni L., Verrillo F., Bartoloni A., Marcucci R., et al. Factors associated with persistence of symptoms 1 year after COVID-19: A longitudinal, prospective phone-based interview follow-up cohort study. Eur. J. Intern. Med. 2022;97:36&#x2013;41. doi: 10.1016/j.ejim.2021.11.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejim.2021.11.018</ArticleId><ArticleId IdType="pmc">PMC8648678</ArticleId><ArticleId IdType="pubmed">34903448</ArticleId></ArticleIdList></Reference><Reference><Citation>Spinicci M., Vellere I., Graziani L., Tilli M., Borchi B., Mencarini J., Campolmi I., Gori L., Rasero L., Fattirolli F., et al. Clinical and Laboratory Follow-up After Hospitalization for COVID-19 at an Italian Tertiary Care Center. Open Forum Infect. Dis. 2021;8:ofab049. doi: 10.1093/ofid/ofab049.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/ofid/ofab049</ArticleId><ArticleId IdType="pmc">PMC7928559</ArticleId><ArticleId IdType="pubmed">34109256</ArticleId></ArticleIdList></Reference><Reference><Citation>World Health Organization . Clinical Management of COVID-19 Interim Guidance. World Health Organization; Geneva, Switzerland: 2020.</Citation></Reference><Reference><Citation>Istituto Superiore di Sanit&#xe0; (Italian National Health Institute)   Prevalenza e Distribuzione delle Varianti di SARSCoV2 di Interesse per la Sanit&#xe0; Pubblica in Italia Rapporto n. 21 (Dati Aggiornati al del 1 Luglio 27 Giugno 2022) Istituto Superiore di Sanit&#xe0;; Rome, Italy: 2022.  [(accessed on 1 October 2022)].  Available online:  https://www.epicentro.iss.it/coronavirus/pdf/sars-cov-2-monitoraggio-varianti-rapporti-periodici-1-luglio-2022.pdf.</Citation></Reference><Reference><Citation>Carf&#xec; A., Bernabei R., Landi F. Gemelli Against COVID-19 Post-Acute Care Study Group. Persistent Symptoms in Patients After Acute COVID-19. JAMA. 2020;324:603&#x2013;605. doi: 10.1001/jama.2020.12603.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Choutka J., Jansari V., Hornig M., Iwasaki A. Unexplained post-acute infection syndromes. Nat. Med. 2022;28:911&#x2013;923. doi: 10.1038/s41591-022-01810-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01810-6</ArticleId><ArticleId IdType="pubmed">35585196</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers J.P., Chesney E., Oliver D., Pollak T.A., McGuire P., Fusar-Poli P., Zandi M.S., Lewis G., David A.S. Psychiatric and neuropsychiatric presentations associated with severe coronavirus infections: A systematic review and meta-analysis with comparison to the COVID-19 pandemic. Lancet Psychiatry. 2020;7:611&#x2013;627. doi: 10.1016/S2215-0366(20)30203-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30203-0</ArticleId><ArticleId IdType="pmc">PMC7234781</ArticleId><ArticleId IdType="pubmed">32437679</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R., Vasconcello-Castillo L., Alsina-Restoy X., Solis-Navarro L., Burgos F., Puppo H., Vilar&#xf3; J. Respiratory function in patients post-infection by COVID-19: A systematic review and meta-analysis. Pulmonology. 2021;27:328&#x2013;337. doi: 10.1016/j.pulmoe.2020.10.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X., Liu X., Zhou Y., Yu H., Li R., Zhan Q., Ni F., Fang S., Lu Y., Ding X., et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: A prospective study. Lancet Respir. Med. 2021;9:747&#x2013;754. doi: 10.1016/S2213-2600(21)00174-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.L., Weitzer D.J. Long COVID and Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)-A Systemic Review and Comparison of Clinical Presentation and Symptomatology. Medicina. 2021;57:418. doi: 10.3390/medicina57050418.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/medicina57050418</ArticleId><ArticleId IdType="pmc">PMC8145228</ArticleId><ArticleId IdType="pubmed">33925784</ArticleId></ArticleIdList></Reference><Reference><Citation>Docherty A.B., Harrison E.M., Green C.A., Hardwick H.E., Pius R., Norman L., Holden K.A., Read J.M., Dondelinger F., Carson G., et al. Features of 20 133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: Prospective observational cohort study. BMJ. 2020;369:m1985. doi: 10.1136/bmj.m1985.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.m1985</ArticleId><ArticleId IdType="pmc">PMC7243036</ArticleId><ArticleId IdType="pubmed">32444460</ArticleId></ArticleIdList></Reference><Reference><Citation>Torjesen I. COVID-19: Middle aged women face greater risk of debilitating long term symptoms. BMJ. 2021;372:n829. doi: 10.1136/bmj.n829.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n829</ArticleId><ArticleId IdType="pubmed">33766927</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., Gillesen A., Berry C., Lowe D.J., McPeake J., et al. Long COVID in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg. Health Eur. 2021;8:100186. doi: 10.1016/j.lanepe.2021.100186.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100186</ArticleId><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F., Tomasoni D., Falcinella C., Barbanotti D., Castoldi R., Mul&#xe8; G., Augello M., Mondatore D., Allegrini M., Cona A., et al. Female gender is associated with long COVID syndrome: A prospective cohort study. Clin. Microbiol. Infect. 2022;28:611.e9&#x2013;611.e16. doi: 10.1016/j.cmi.2021.11.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2021.11.002</ArticleId><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Stewart S., Newson L., Briggs T.A., Grammatopoulos D., Young L., Gill P. Long COVID risk&#x2014;A signal to address sex hormones and women&#x2019;s health. Lancet Reg. Health Eur. 2021;11:100242. doi: 10.1016/j.lanepe.2021.100242.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.lanepe.2021.100242</ArticleId><ArticleId IdType="pmc">PMC8561426</ArticleId><ArticleId IdType="pubmed">34746909</ArticleId></ArticleIdList></Reference><Reference><Citation>Takahashi T., Ellingson M.K., Wong P., Israelow B., Lucas C., Klein J., Silva J., Mao T., Oh J.E., Tokuyama M., et al. Sex differences in immune responses that underlie COVID-19 disease outcomes. Nature. 2020;588:315&#x2013;320. doi: 10.1038/s41586-020-2700-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-020-2700-3</ArticleId><ArticleId IdType="pmc">PMC7725931</ArticleId><ArticleId IdType="pubmed">32846427</ArticleId></ArticleIdList></Reference><Reference><Citation>Bin Huang B., Cai Y., Li N., Li K., Wang Z., Li L., Wu L., Zhu M., Li J., Wang Z., et al. Sex-based clinical and immunological differences in COVID-19. BMC Infect. Dis. 2021;21:647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8256650</ArticleId><ArticleId IdType="pubmed">34225644</ArticleId></ArticleIdList></Reference><Reference><Citation>Wenham C., Smith J., Morgan R. Gender and COVID-19 Working Group. COVID-19: The gendered impacts of the outbreak. Lancet. 2020;395:846&#x2013;848. doi: 10.1016/S0140-6736(20)30526-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30526-2</ArticleId><ArticleId IdType="pmc">PMC7124625</ArticleId><ArticleId IdType="pubmed">32151325</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortona E., Buonsenso D., Carfi A., Malorni W. Long COVID Kids study group. Long COVID: An estrogen-associated autoimmune disease? Cell Death Discov. 2021;7:77. doi: 10.1038/s41420-021-00464-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41420-021-00464-6</ArticleId><ArticleId IdType="pmc">PMC8042352</ArticleId><ArticleId IdType="pubmed">33850105</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend L., Dyer A.H., Jones K., Dunne J., Mooney A., Gaffney F., O&#x2019;Connor L., Leavy D., O&#x2019;Brien K., Dowds J., et al. Persistent fatigue following SARS-CoV-2 infection is common and independent of severity of initial infection. PLoS ONE. 2020;15:e0240784. doi: 10.1371/journal.pone.0240784.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0240784</ArticleId><ArticleId IdType="pmc">PMC7652254</ArticleId><ArticleId IdType="pubmed">33166287</ArticleId></ArticleIdList></Reference><Reference><Citation>Davies N.G., Jarvis C.I., Edmunds W.J., Jewell N.P., Diaz-Ordaz K., Keogh R.H., CMMID COVID-19 Working Group Increased mortality in community-tested cases of SARS-CoV-2 lineage B.1.1.7. Nature. 2021;593:270&#x2013;274. doi: 10.1038/s41586-021-03426-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03426-1</ArticleId><ArticleId IdType="pmc">PMC9170116</ArticleId><ArticleId IdType="pubmed">33723411</ArticleId></ArticleIdList></Reference><Reference><Citation>Elliott J., Whitaker M., Bodinier B., Eales O., Riley S., Ward H., Cooke G., Darzi A., Chadeau-Hyam M., Elliott P. Predictive symptoms for COVID-19 in the community: REACT-1 study of over 1 million people. PLoS Med. 2021;18:e1003777. doi: 10.1371/journal.pmed.1003777.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1003777</ArticleId><ArticleId IdType="pmc">PMC8478234</ArticleId><ArticleId IdType="pubmed">34582457</ArticleId></ArticleIdList></Reference><Reference><Citation>Klimek L., Hagemann J., Hummel T., Altundag A., Hintschich C., Stielow S., Bousquet J. Olfactory dysfunction is more severe in wild-type SARS-CoV-2 infection than in the Delta variant (B.1.617.2) World Allergy Organ. J. 2022;15:100653. doi: 10.1016/j.waojou.2022.100653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.waojou.2022.100653</ArticleId><ArticleId IdType="pmc">PMC9095455</ArticleId><ArticleId IdType="pubmed">35578676</ArticleId></ArticleIdList></Reference><Reference><Citation>Butowt R., Bili&#x144;ska K., von Bartheld C. Why does the Omicron Variant Largely Spare Olfactory Function? Implications for the Pathogenesis of Anosmia in COVID-19. J. Infect. Dis. 2022;226:1304&#x2013;1308. doi: 10.1093/infdis/jiac113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiac113</ArticleId><ArticleId IdType="pmc">PMC9129133</ArticleId><ArticleId IdType="pubmed">35467743</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodriguez-Sevilla J.J., G&#xfc;erri-Fern&#xe1;dez R., Bertran Recasens B. Is There Less Alteration of Smell Sensation in Patients with Omicron SARS-CoV-2 Variant Infection? Front. Med. 2022;9:852998. doi: 10.3389/fmed.2022.852998.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.852998</ArticleId><ArticleId IdType="pmc">PMC9039252</ArticleId><ArticleId IdType="pubmed">35492353</ArticleId></ArticleIdList></Reference><Reference><Citation>von Bartheld C.S., Hagen M.M., Butowt R. The D614G virus mutation enhances anosmia in COVID-19 patients: Evidence from a systematic review and meta-analysis of studies from South Asia. ACS Chem. Neurosci. 2021;12:3535&#x2013;3549. doi: 10.1021/acschemneuro.1c00542.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.1c00542</ArticleId><ArticleId IdType="pmc">PMC8482322</ArticleId><ArticleId IdType="pubmed">34533304</ArticleId></ArticleIdList></Reference><Reference><Citation>Taquet M., Luciano S., Geddes J.R., Harrison P.J. Bidirectional associations between COVID-19 and psychiatric disorder: Retrospective cohort studies of 62 354 COVID-19 cases in the USA. Lancet Psychiatry. 2021;8:130&#x2013;140. doi: 10.1016/S2215-0366(20)30462-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2215-0366(20)30462-4</ArticleId><ArticleId IdType="pmc">PMC7820108</ArticleId><ArticleId IdType="pubmed">33181098</ArticleId></ArticleIdList></Reference><Reference><Citation>UK Health Security Agency  UKHSA Review Shows Vaccinated Less Likely to Have Long COVID Than Unvaccinated. Press Release. Published 15 February 2022.  [(accessed on 1 October 2022)]; Available online:  https://www.gov.uk/government/news/ukhsa-review-shows-vaccinated-less-likely-to-have-long-covid-than-unvaccinated.</Citation></Reference><Reference><Citation>Al-Aly Z., Bowe B., Xie Y. Long COVID after breakthrough SARS-CoV-2 infection. Nat. Med. 2022;28:1461&#x2013;1467. doi: 10.1038/s41591-022-01840-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01840-0</ArticleId><ArticleId IdType="pmc">PMC9307472</ArticleId><ArticleId IdType="pubmed">35614233</ArticleId></ArticleIdList></Reference><Reference><Citation>Ayoubkhani D., Bermingham C., Pouwels K.B., Glickman M., Nafilyan V., Zaccardi F., Khunti K., A Alwan N., Walker A.S. Trajectory of long COVID symptoms after COVID-19 vaccination: Community based cohort study. BMJ. 2022;377:e069676. doi: 10.1136/bmj-2021-069676.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj-2021-069676</ArticleId><ArticleId IdType="pmc">PMC9115603</ArticleId><ArticleId IdType="pubmed">35584816</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., O&#x2019;Hara M.E., Akrami A., Perego E., Olliaro P., Needham D.M. Long COVID: Aiming for a consensus. Lancet Respir. Med. 2022;10:632&#x2013;634. doi: 10.1016/S2213-2600(22)00135-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00135-7</ArticleId><ArticleId IdType="pmc">PMC9067938</ArticleId><ArticleId IdType="pubmed">35525253</ArticleId></ArticleIdList></Reference><Reference><Citation>Munblit D., Nicholson T., Akrami A., Apfelbacher C., Chen J., De Groote W., Diaz J.V., Gorst S.L., Harman N., Kokorina A., et al. A core outcome set for post-COVID-19 condition in adults for use in clinical practice and research: An international Delphi consensus study. Lancet Respir. Med. 2022;10:715&#x2013;724. doi: 10.1016/S2213-2600(22)00169-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(22)00169-2</ArticleId><ArticleId IdType="pmc">PMC9197249</ArticleId><ArticleId IdType="pubmed">35714658</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>